CG Oncology (CGON) EV to EBITDA (2024 - 2026)
Powered by 
Analysis
CG Oncology (CGON) EV to EBITDA (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn |
| 10 | CG Oncology | 6.56 Bn | 6.56 Bn | -2.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -60.72 |
| Mar 31, 2026 | -73.51 |
| Dec 31, 2025 | -53.55 |
| Sep 30, 2025 | -48.36 |
| Jun 30, 2025 | -27.10 |
| Mar 31, 2025 | -27.92 |
| Dec 31, 2024 | -27.61 |
| Sep 30, 2024 | -70.95 |
| Jun 30, 2024 | -60.02 |
| Mar 31, 2024 | -66.74 |